a 2021

Arterial stiffness and cardiometabolic-based chronic disease: the Kardiovize study

PAVLOVSKA, Iuliia, J.I. MECHANICK, G. A. MARANHAO NETO, M. M. INFANTE GARCIA, R. NIETO MARTINEZ et. al.

Basic information

Original name

Arterial stiffness and cardiometabolic-based chronic disease: the Kardiovize study

Authors

PAVLOVSKA, Iuliia, J.I. MECHANICK, G. A. MARANHAO NETO, M. M. INFANTE GARCIA, R. NIETO MARTINEZ, Šárka KUNZOVÁ, Anna POLCROVÁ, Robert VYSOKÝ, J.R. MEDINA INOJOSA, F. LOPEZ JIMENEZ, G. B. STOKIN and J. P. GONZÁLEZ RIVAS

Edition

European Congress on Obesity (ECO Online 2021) 28th Congress, 10-13 May, 2021. 2021

Other information

Language

English

Type of outcome

Konferenční abstrakt

Field of Study

30308 Nutrition, Dietetics

Country of publisher

Switzerland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 4.807

Organization unit

Faculty of Medicine

ISSN

UT WoS

000651888400001

Tags

Tags

International impact, Reviewed
Změněno: 15/9/2021 10:25, Mgr. Iuliia Pavlovska, Ph.D.

Abstract

V originále

Arterial stiffness (ArSt) describes a loss of arterial wall elasticity and it is an independent predictor of cardiovascular events¹. A cardiometabolic-based chronic disease (CMBCD)² model integrates concepts of adiposity-based chronic disease(ABCD)³, dysglycemia-based chronic disease (DBCD)⁴, and cardiovascular disease (CVD). We hypothesized that compared to traditional adiposity and dysglycemia classifiers, complication-centric ABCD and DBCD models will detect more people with high ArSt, using the cardio-ankle vascular index (CAVI).